CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12 (2014)
- Authors:
- USP affiliated author: TRAINA, FABÍOLA - FMRP
- School: FMRP
- DOI: 10.1371/journal.pone.0091365
- Subjects: MEDULA ÓSSEA (METABOLISMO); CITOMETRIA DE FLUXO; REGULAÇÃO GÊNICA; EXPRESSÃO GÊNICA; LEUCEMIA (GENÉTICA)
- Language: Inglês
- Imprenta:
- Place of publication: San Francisco
- Date published: 2014
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MELO, Rita de Cássia Carvalho; LONGHINI, Ana Leda; BIGARELLA, Carolina Louzão; et al. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12. PLOS ONE, San Francisco, v. 9, n. 1, p. e85926-1 - e85926-12, 2014. Disponível em: < http://dx.doi.org/10.1371/journal.pone.0091365 > DOI: 10.1371/journal.pone.0091365. -
APA
Melo, R. de C. C., Longhini, A. L., Bigarella, C. L., Baratti, M. O., Traina, F., Favaro, P., et al. (2014). CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12. PLOS ONE, 9( 1), e85926-1 - e85926-12. doi:10.1371/journal.pone.0091365 -
NLM
Melo R de CC, Longhini AL, Bigarella CL, Baratti MO, Traina F, Favaro P, Campos P de M, Saad STO. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12 [Internet]. PLOS ONE. 2014 ; 9( 1): e85926-1 - e85926-12.Available from: http://dx.doi.org/10.1371/journal.pone.0091365 -
Vancouver
Melo R de CC, Longhini AL, Bigarella CL, Baratti MO, Traina F, Favaro P, Campos P de M, Saad STO. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12 [Internet]. PLOS ONE. 2014 ; 9( 1): e85926-1 - e85926-12.Available from: http://dx.doi.org/10.1371/journal.pone.0091365 - Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes
Informações sobre o DOI: 10.1371/journal.pone.0091365 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
